The HyaloFAST® is a very important and unique study, a quite prestigious one of its kind. The study has a critical purpose and will be vital to learn the potential future treatments for knee repair.

The purpose of this study is to evaluate the safety and efficacy of Hyalofast® scaffold with bone marrow aspirate concentrate (BMAC) compared to microfracture in the treatment of symptomatic cartilage defects of the knee.

This is a clinical, randomized trial in its recruiting phase. Participants are to be 18-60 years of age, and have a has a symptomatic lesion of the femoral condyle (medial and/or lateral) or femoral trochlea that is between 1-6 cm2 on screening images confirmed by the independent radiologist.

Dr. Kevin Darr is one of the only doctors in the United States to be able to partake in this fascinating opportunity.

For more information on this trial, or to see if you are eligible, please contact the clinic at (985) 274-5588.

‍

‍